Source: Facebook.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • NervGen Pharma (NGEN) is granting 150,000 incentive stock options
  • Stocks are offered at C$1.99 per share for first 5 years
  • NervGen (NGEN) is a clinical biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease.
  • NervGen Pharma (NGEN) is currently trading at C$1.97 as of 11:30am ET

NervGen Pharma (NGEN) announced that it is granting 150,000 incentive stock options.

The company focuses on clinical-stage biotech and is dedicated to developing a first-in-class neutoreparative drug to treat nervous system damage. The stock is offered at C$1.99 per share for five years. The incentive stock option will vest equally every three months for one year. All options are granted in accordance with the policies of the TSX Venture Exchange and the conditions of the company’s stock option plan.

NervGen (NGEN) is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease.

NervGen Pharma (NGEN) is currently trading at C$1.97 as of 11:30am ET.

More From The Market Herald
The Market Herald Video

" RevoluGROUP Canada’s (TSXV:REVO) RevoluSEND and RevoluTRANSFER extend financial reach to 120 countries

RevoluGROUP Canada (REVO) announced that RevoluSEND and RevoluTRANSFER now include the United Kingdom.

" Colliers (TSX:CIGI) expands offering in Belgium

Colliers (CIGI) has acquired a majority interest in BelSquare SRL, a leading Belgian commercial real estate advisor.

" Mink Ventures (TSXV:MINK.P) updates terms of private placement

Mink Ventures (MINK.P) has updated the terms of a non-brokered private placement in connection with its proposed qualifying transaction with Voltage Metals.

" Everyday People (TSXV:EPF) secures $5.9 million in credit

Everyday People Financial (EPF) has signed two new credit arrangements worth a total of $5.9 million.